RecruitingNCT05776225

Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection

Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection (PHINDER)

Sponsor

United Therapeutics

Enrollment

300 participants

Start Date

Aug 11, 2023

Study Type

OBSERVATIONAL

Conditions

Interstitial Lung Disease Pulmonary Hypertension

Summary

Study GMS-PH-001 is a multicenter, open-label, non-randomized study to prospectively evaluate screening strategies of pulmonary hypertension (PH) in patients with interstitial lung disease (ILD).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is screening people with interstitial lung disease (ILD) — a group of conditions that cause scarring and inflammation of the lung tissue — for pulmonary hypertension (high blood pressure in the lungs), which is a serious and often underdiagnosed complication. Catching pulmonary hypertension early may allow for faster and more effective treatment. **You may be eligible if...** - You have been diagnosed with an ILD such as idiopathic pulmonary fibrosis, hypersensitivity pneumonitis, scleroderma-related lung disease, or autoimmune lung disease - You can read and understand English or Spanish questionnaires - You have given voluntary written consent to participate **You may NOT be eligible if...** - You have a lung condition not listed among the specified ILD types - You are unable to provide informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURERight heart catheterization (RHC)

RHC to evaluate pulmonary hemodynamics

Locations(42)

Pulmonary Associates

Phoenix, Arizona, United States

Hartford Hospital

Hartford, Connecticut, United States

Lakeland Regional Health

Lakeland, Florida, United States

NCH Healthcare System

Naples, Florida, United States

University of South Florida Health

Tampa, Florida, United States

Cleveland Clinic Florida

Weston, Florida, United States

Emory University Hospital

Atlanta, Georgia, United States

Piedmont Healthcare

Austell, Georgia, United States

Loyola University Chicago

Chicago, Illinois, United States

Northwestern University

Chicago, Illinois, United States

NorthShore University Health System

Glenview, Illinois, United States

University of Kentucky Medical Center

Lexington, Kentucky, United States

LSU Health Sciences Center New Orleans

New Orleans, Louisiana, United States

University of Michigan Int Med Pulmonary and Critical Care

Ann Arbor, Michigan, United States

Mclaren Greater Lansing

Okemos, Michigan, United States

Blessing Health Hannibal

Hannibal, Missouri, United States

Renown Regional Medical Center

Reno, Nevada, United States

Dartmouth Hitchcock Medical Center

Lebanon, New Hampshire, United States

Jersey Shore University Medical Center

Neptune City, New Jersey, United States

NYU Langone Medical Center

New York, New York, United States

Montefiore Medical Center

The Bronx, New York, United States

Duke University Medical Center

Durham, North Carolina, United States

Pulmonix, LLC

Greensboro, North Carolina, United States

East Carolina University

Greenville, North Carolina, United States

Legacy Health

Portland, Oregon, United States

St. Luke's University Health Network

Bethlehem, Pennsylvania, United States

AnMed Health Pulmonary and Sleep Medicine

Anderson, South Carolina, United States

Prisma Health

Columbia, South Carolina, United States

StatCare Pulmonary Consultants

Knoxville, Tennessee, United States

Premier Pulmonary Critical Care and Sleep Medicine

Denison, Texas, United States

Houston Methodist Hospital

Houston, Texas, United States

The University of Texas Health Science Center at San Antonio

San Antonio, Texas, United States

Intermountain Healthcare

Murray, Utah, United States

University of Utah Health

Salt Lake City, Utah, United States

The University of Vermont Medical Center

Burlington, Vermont, United States

University of Virginia

Charlottesville, Virginia, United States

Inova Fairfax Hospital

Falls Church, Virginia, United States

Sentara Cardiovascular Research Institute

Norfolk, Virginia, United States

Pulmonary Associates of Richmond

Richmond, Virginia, United States

Providence Medical Research Center

Spokane, Washington, United States

Marshall Health

Huntington, West Virginia, United States

Medical College of Wisconsin

Milwaukee, Wisconsin, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05776225

Related Trials

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

NCT05943535153 locations

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

NCT0707382022 locations

Phenotyping Resting and Exertional Right Ventricular Dysfunction Among Patients With Chronic Obstructive Pulmonary Disease

NCT058965791 location

Right Ventricular Response to Exercise Among Patients With Chronic Obstructive Pulmonary Disease

NCT075768941 location

Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis

NCT075723831 location